Finance

Two Stocks in Concentration: Nuveen New York AMT-Free Quality Municipal (NYSE:NRK), Nobilis Health Corp. (NYSE:HLTH)

Nuveen New York AMT-Free Quality Municipal (NYSE:NRK)’s Financial Overview

Nuveen New York AMT-Free Quality Municipal (NYSE) surged 0.16% yesterday to close its trading session at $12.54. Nuveen New York AMT-Free Quality Municipal has 52-Week high of $12.56 and 52-Week Low of $11.48. The stock touched its 52-Week High on 12.54 and 52-Week Low on 11.48. The stock traded with the volume of 89444 shares yesterday. The firm shows the market capitalization of $1.1 Billion.

The firm is trading with SMA20 of 1.38 Percent, SMA50 of 3.13 Percent and SMA200 of 4.61 percent. Nuveen New York AMT-Free Quality Municipal has P/S value of 13.7 while its P/B value stands at 0.89. Similarly, the company has Return on Assets of 0 percent, Return on Equity of 0 percent and Return on Investment of 0 Percent. The company shows Gross Margin and Operating Margin of 0 percent and 0 percent respectively.

The Stock currently has Analyst’ mean Recommendation of 0 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.

There is no forecast data available.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

Nobilis Health Corp. (NYSE:HLTH)

Nobilis Health Corp. own and manage ambulatory and acute care facilities for healthcare services. In addition, it owns and manages ambulatory surgery centers, acute care hospital, imaging centers and urgent care clinic. The company operates primarily in Houston, Dallas and Scottsdale, Arizona. Nobilis Health Corp. is headquartered in Houston, Texas.

Nobilis Health Corp. (NYSE:HLTH)’s Financial Outlook

The 1 analysts offering 12-month price forecasts for Nobilis Health Corp have a median target of 2.00, with a high estimate of 2.00 and a low estimate of 2.00. The median estimate represents a +409.94% increase from the last price of 0.39.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

According to Zacks Investment Research, Nobilis Health Corp. has a Consensus Recommendation of 1. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).

The Stock declined -1.93% and closed its last trading session at $0.39. The company has the market capitalization of $32.02 Million. The stock has 52-week high of $1.7 and 52-Week low of $0.17. The firm touched its 52-Week high on 1.70 and 52-Week low on 0.17. The company has volume of 62971 shares. The company has a total of 81.64 Million shares outstanding.

Nobilis Health Corp. (NYSE) in the last quarter reported its actual EPS of $0.01/share where the analyst estimated EPS was $0.02/share. The difference between the actual and Estimated EPS is $-0.01. This shows a surprise factor of -50 percent.

The company has YTD performance of -6.62 percent. Beta for Nobilis Health Corp. stands at -0.21 while its ATR (average true range) is 0.04. The company has Weekly Volatility of 6.69%% and Monthly Volatility of 9.60%%.

Nobilis Health Corp. has distance from 20-day Simple Moving Average (SMA20) of -3.2%, Distance from 50-Day Simple Moving Average of -7.27 percent and Distance from 200-Day Simple Moving Average of -48.27%.

The Company currently has ROA (Return on Assets) of 0.4 percent, Return on Equity (ROE) of 1.1 Percent and Return on Investment (ROI) of 3.5% with Gross margin of 0 percent and Operating & Profit margin of 6.9% and 0.6% respectively.